KDM1A and ovarian carcinoma: Treatment of uterine serous carcinoma ARK2 cells and ovarian cancer TOV112D cells with two different LSD1 siRNAs (#1 and #2) significantly reduced LSD1 protein expression (-75% and -90%, respectively; Figure 1B and Supplementary Figure 1).